Milestone Scientific (MLSS) Current Deferred Revenue (2014 - 2021)

Milestone Scientific has disclosed Current Deferred Revenue across 7 years of filings, most recently posting $407050.0 for Q3 2021.

• Current Deferred Revenue for Q3 2021 came in at $407050.0, up 19.55% year-over-year; the trailing twelve-month figure through Sep 2021 was $407050.0 (up 19.55% YoY), and the FY2020 annual result was $242589.0, down 28.75% from the prior year.
• Current Deferred Revenue came in at $407050.0 for Q3 2021 at Milestone Scientific, up from $337145.0 in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $1.7 million in Q4 2017 to a low of $241288.0 in Q1 2021.
• The 5-year median for Current Deferred Revenue is $372700.0 (2019), against an average of $523654.1.
• Across the five-year window, Current Deferred Revenue soared 173.45% in 2017 and tumbled 75.55% in 2018, its largest moves.
• Milestone Scientific's Current Deferred Revenue stood at $1.7 million in 2017, then slumped by 75.55% to $421800.0 in 2018, then decreased by 19.28% to $340476.0 in 2019, then dropped by 28.75% to $242589.0 in 2020, then surged by 67.79% to $407050.0 in 2021.
• The last three Current Deferred Revenue figures came in at $407050.0 (Q3 2021), $337145.0 (Q2 2021), and $241288.0 (Q1 2021), per Business Quant data.